Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous Myografts Transplantation for Muscle Atrophy
NCT07426068Phase 1Not yet recruiting
- Start
- Jul 2026
- Primary completion
- Feb 2028
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of autologous differentiated myocytes in muscle atrophy. Primary endpoints: Blood pressure, Heart rate and 13 more. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
autologous differentiated myocytes
03
Conditions
muscle atrophy
Beyond the preview
Go deeper on NCT07426068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07426068.